Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis

Journal of Applied Physiology

Volumn 84, Issue 1, 1998, Pages 107-115

  Quezado, Zenaide M N ^a   Natanson, Charles ^a   Karzai, Waheedullah ^a   Danner, Robert L ^a   Koev, Cezar A ^a   Fitz, Yvonne ^a   Dolan, Donald P ^a   Richmond, Steven ^a   Banks, Steven M ^a   Wilson, Laura ^a   Eichacker, Peter Q ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Escherichia coli; Fractional inspired oxygen; Hypoxemia; Pulmonary artery pressure

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HEMODYNAMIC PARAMETERS; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPSIS;

EID: 0031932757     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.84.1.107     Document Type: Article

References (61)

1. Barbera, J. A., N. Roger, J. Roca, I. Rovira, T. W. Higenbottam, and R. Rodriguez-Roisin. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 347: 436-440, 1996.
2. Barnard, J. W., P. S. Wilson, T. M. Moore, W. J. Thompson, and A. E. Taylor. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol. 74: 2940-2948, 1993.
3. Berger, J. I., R. L. Gibson, G. J. Redding, T. A. Standaert, W. R. Clarke, and W. E. Truog. Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am. Rev. Respir. Dis. 147: 1080-1086, 1993.
4. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, Jr., and W. M. Zapol. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80: 761-770, 1994.
5. Cioffi, W. G., and H. Ogura. Inhaled nitric oxide in acute lung disease. New Horiz. 3: 73-85, 1995.
6. Cobb, J. P., C. Natanson, Z. M. N. Quezado, W. D. Hoffman, C. A. Koev, S. Banks, R. Correa, R. Levi, R. J. Elin, J. M. Hosseini, and R. L. Danner. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1634-H1642, 1995.
7. Cutaia, M., and S. Rounds. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance. Chest 97: 706-718, 1990.
8. Dyar, O., J. D. Young, L. Xiong, S. Howell, and E. Johns. Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br. J. Anaesth. 71: 702-708, 1993.
9. Eichacker, P. Q., W. D. Hoffman, A. Farese, S. M. Banks, G. C. Kuo, T. J. MacVittie, and C. Natanson. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J. Appl. Physiol. 71: 1979-1989, 1991.
10. Emil, S. G., J. E. Berkeland, and J. B. Atkinson. Nitric oxide dose response during moderate and severe hypoxia in swine. Ann. Thorac. Surg. 63: 414-418, 1997.
11. Finer, N. N., P. C. Etches, B. Kamstra, A. J. Tierney, A. Peliowski, and C. A. Ryan. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J. Pediatr. 124: 302-308, 1994.
12. Fratacci, M. D., C. G. Frostell, T. Y. Chen, J. C. Wain, D. R. Robinson, and W. M. Zapol. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75: 927-931, 1991.
13. Freeman, B. D., Z. Quezado, F. Zeni, C. Natanson, R. L. Danner, S. Banks, M. Quezado, Y. Fitz, J. Bacher, and P. Q. Eichacker. rG-CSF reduces endotoxemia, and improves survival during E. coli pneumonia. J. Appl. Physiol. 83: 1467-1475, 1997.
14. Frostell, C., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
15. Gerlach, H., R. Rossaint, D. Pappert, and K. J. Falke. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur. J. Clin. Invest. 23: 499-502, 1993.
16. Girard, P., and P. Potier. NO, thiols and disulfides. FEBS Lett. 320: 7-8, 1993.
17. Graham, L. M., A. Vasil, M. L. Vasil, N. F. Voelkel, and K. R. Stenmark. Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am. Rev. Respir. Dis. 142: 221-229, 1990.
18. Hanly, P., A. Sienko, and R. B. Light. Effect of cyclooxygenase blockade on gas exchange and hemodynamics in Pseudomonas pneumonia. J. Appl. Physiol. 63: 1829-1836, 1987.
19. Hutchison, A. A., M. L. Ogletree, J. R. Snapper, and K. L. Brigham. Effect of endotoxemia on hypoxic pulmonary vasconstriction in unanesthetized sheep. J. Appl. Physiol. 58: 1463-1468, 1985.
20. 2. J. Appl. Physiol. 45: 408-413, 1978.
21. Kinsella, J. P, S. R. Neish, D. D. Ivy, E. Shaffer, and S. H. Abman. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. 123: 103-108, 1993.
22. Klemm, P., C. Thiemermann, G. Winklmaier, P. A. Martorana, and R. Henning. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br. J. Pharmacol. 114: 363-368, 1995.
23. Kollef, M. H., and D. P. Schuster. The acute respiratory distress syndrome. N. Engl. J. Med. 332: 27-37, 1995.
24. Light, R. B., S. N. Mink, and L. D. H. Wood. Pathophysiology of gas exchange and pulmonary perfusion in pneumococcal lobar pneumonia in dogs. J. Appl. Physiol. 50: 524-530, 1981.
25. Maggiorini, M., S. Brimioulle, D. De Canniere, M. Del-Croix, P. Wauthy, and R. Naeije. Pulmonary vascular impedance response to hypoxia in dogs and minipigs: effects of inhaled nitric oxide. J. Appl. Physiol. 79: 1156-1162, 1995.
26. Marshall, B. E., C. W. Hanson, F. Frasch, and C. Marshall. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology. Intensive Care Med. 20: 379-389, 1994.
27. Marshall, B. E., C. Marshall, J. Benumof, and L. J. Saidman. Hypoxic pulmonary vasoconstriction in dogs: effects of lung segment size and oxygen tension. J. Appl. Physiol. 51: 1543-1551, 1981.
28. Marshall, B. E., C. Marshall, and C. W. Hanson. Role of hypoxic vasoconstriction in pulmonary gas exchange and blood flow distribution. 1. Physiologic concepts. Intensive Care Med. 20: 291-297, 1994.
29. Martin, C. M., A. Yaghi, W. J. Sibbald, D. McCormack, and N. A. M. Paterson. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am. Rev. Respir. Dis. 148: 164-172, 1993.
30. Martin, W., J. A. Smith, and D. G. White. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilaators, nitric oxide, or bovine retractor penis inhibitory factor. Br. J. Pharmacol. 89: 563-571, 1986.
31. McCormack, D. G. Control of vascular reactivity. New Horiz. 3: 248-256, 1993.
32. 2 mechanisms of guanylate cyclase activation in oxygen-dependent responses of rat pulmonary circulation. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L546-L550, 1995.
33. Natanson, C., M. P. Fink, H. K. Ballantine, T. J. MacVittie, J. J. Conklin, and J. E. Parrillo. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J. Clin. Invest. 78: 259-270, 1986.
34. Ogura, H., W. G. Cioffi, Jr., B. S. Jordan, C. V. Okerberg, A. A. Mason Johnson, A. D. Mason, Jr., and B. A. Pruitt, Jr.. The effect of inhaled nitric oxide on smoke inhalation injury in an ovine model. J. Trauma 37: 294-301, 1994.
35. Ogura, H., W. G. Cioffi, P. J. Offner, B. S. Jordan, A. A. Johnson, and B. A. Pruitt. Effect of inhaled nitric oxide on pulmonary function after sepsis in a swine model. Surgery 116: 313-321, 1994.
36. Ogura, H., P. J. Offner, D. Saitoh, B. S. Jordan, A. A. Johnson, B. A. Pruitt, and W. G. Cioffi. The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model. Arch. Surg. 129: 1233-1239, 1994.
37. 1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Crit. Care Med. 19: 60-67, 1991.
38. Putensen, C., J. Rasanen, and J. B. Downs. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am. J. Respir. Crit. Care Med. 150: 330-336, 1994.
39. Putensen, C., J. Rasanen, F. A. Lopez, and J. B. Downs. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 106: 1563-1569, 1994.
40. Puybasset, L., J. J. Rouby, E. Mourgeon, P. Cluzel, Z. Souhil, J. D. Law-Koune, T. Stewart, C. Devilliers, Q. Lu, S. Roche, P. Kalfon, E. Vicaut, and P. Viars. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am. J. Respir. Crit. Care Med. 152: 318-328, 1995.
41. Puybasset, L., J. J. Rouby, E. Mourgeon, T. E. Stewart, P. Cluzel, M. Arthaud, P. Poete, L. Bodin, A. M. Korinek, and P. Viars. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med. 20: 319-327, 1994.
42. Radermacher, P., B. Santak, H. J. Wust, J. Tarnow, and K. J. Falke. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238-244, 1990.
43. Reeves, J. T., and R. F. Grover. Blockade of acute hypoxic pulmonary hypertension by endotoxin. J. Appl. Physiol. 36: 328-332, 1974.
44. Rimar, S., and C. N. Gillis. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88: 2884-2887, 1993.
45. Roberts, J. D., Jr., T. Y. Chen, N. Kawai, J. Wain, P. Duppuy, A. Shimouchi, K. Bloch, D. Polaner, and W. M. Zapol. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ. Res. 72: 246-254, 1993.
46. Romand, J. A., M. R. Pinsky, L. Firestone, H. A. Zar, and J. R. Lancaster, Jr. Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog. J. Appl. Physiol. 76: 1350-1355, 1994.
47. Romand, J. A., M. R. Pinsky, L. Firestone, H. A. Zar, and J. R. Lancaster, Jr. Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs. J. Appl. Physiol. 76: 1356-1362, 1994.
48. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 3288: 399-405, 1993.
49. Rovira, I., T. Y. Chen, M. Winkler, N. Kawai, K. D. Bloch, and W. M. Zapol. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J. Appl. Physiol. 76: 345-355, 1994.
50. Scheffé, H. The Analysis of Variance. New York: Wiley, 1959, p. 73-75.
51. Shah, N. S., D. K. Nakayama, T. D. Jacob, I. Nishio, I. Taiyo, T. R. Billiar, R. Exler, and S. A. Yousem. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch. Surg. 129: 158-164, 1994.
52. Shah, N. S., D. K. Nakayama, I. Nishio, T. Imai, T. D. Jacob, R. Exler, T. R. Billiar, E. K. Motoyama, S. A. Yousem, and A. B. Peitzman. Limited efficacy of inhaled nitric oxide in a porcine model of severe acute lung injury. Surg. Forum 33: 55-57, 1993.
53. Stamler, J. S., O. Jaraki, J. Osborne, D. I. Simon, J. Keaney, J. Vita, D. Singel, C. Valeri, and J. Loscalzo. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89: 7674-7677, 1992.
54. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, T. Michel, D. J. Singel, and J. Loscalzo. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89: 444-448, 1992.
55. Stone, J. R., and M. A. Marlette. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric state. Biochemistry 33: 5636-5640, 1994.
56. Van Camp, J. R., C. Yian, and F. M. Lupinetti. Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide. Ann. Thorac. Surg. 58: 1025-1030, 1994.
57. Weir, E. K., J. Mlczoch, J. T. Reeves, and R. F. Grover. Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J. Lab. Clin. Med. 88: 975-983, 1976.
58. Weitzberg, E., A. Rudehill, K. Alving, and J. M. Lundberg. Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock. Acta Physiol. Scand. 1433: 451-452, 1991.
59. G-nitro-L-arginine infusion in porcine endotoxin shock. Crit. Care Med. 23: 909-918, 1995.
60. Wennmalm, A., G. Benthin, A. Edlund, L. Jungersten, N. Kierler-Jensen, S. Lundin, U. N. Westfeld, A. S. Peterson, and F. Waagstein. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ. Res. 73: 1121-1127, 1993.
61. Zapol, W. M., and M. T. Snider. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296: 476-480, 1977.